Correlation Between Anebulo Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Blueprint Medicines Corp, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Anebulo Pharmaceuticals and Blueprint Medicines
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Anebulo and Blueprint is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Blueprint Medicines. In addition to that, Anebulo Pharmaceuticals is 2.08 times more volatile than Blueprint Medicines Corp. It trades about -0.18 of its total potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.18 per unit of volatility. If you would invest 8,751 in Blueprint Medicines Corp on September 1, 2024 and sell it today you would earn a total of 887.00 from holding Blueprint Medicines Corp or generate 10.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Blueprint Medicines Corp |
Anebulo Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Anebulo Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Anebulo Pharmaceuticals vs. Tff Pharmaceuticals | Anebulo Pharmaceuticals vs. Eliem Therapeutics | Anebulo Pharmaceuticals vs. Inhibrx | Anebulo Pharmaceuticals vs. Enliven Therapeutics |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |